evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/geneAliases/6,gene/geneAliases/7,gene/geneAliases/8,gene/geneAliases/9,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract
19724,GENE_BACKGROUND,,"MAPK3 (mitogen-activated protein kinase 3, also known as ERK1) is a mitogen-activated protein (MAP) kinase considered an effector kinase in the RAS/RAF/MEK/ERK pathway. This pathway is triggered by mitosis and differentiation factors as well as cytokines, resulting in MEK1/2-mediated phosphorylation of MAPK3, which induces its homodimerization and translocation to the nucleus where it phosphorylates target proteins (PMID: 9604935, 9166761, 17496918). MAPK3 targets include cytoskeletal molecules and nucleoporins, but foremost kinases and transcription factors with central roles in cell proliferation and survival, including include RSK (ribosomal S6 kinase) and MSK ( mitogen- and stress-activated protein kinases), MYC, c-FOS, ELK-1, ETS-1 and MITF (PMID: 25320010, 22569528). MAPK3 and its homolog, MAPK1 (ERK2), are essential for cell proliferation; they are ubiquitously and often simultaneously expressed, but evidence suggests they may have some distinct functions in specialized contexts (PMID: 23482492, 21248139, 17496918). MAPK3 is mutated at low frequency in various types of cancers. Inhibitors of MAPK1/3 are being explored as complementary and alternative options to RAF and MEK inhibition in cases of resistance or partial response (PMID: 25435214).",,2017-04-10,,5595,MAPK3,mitogen-activated protein kinase 3,False,ENST00000263025,NM_002746.2,ERK-1,P44MAPK,PRKM3,ERK1,HUMKER1A,HS44KDAP,P44ERK1,ERT2,p44-MAPK,p44-ERK1,False,21248139,Deletion of ERK1 and ERK2 in the CNS causes cortical abnormalities and neonatal lethality: Erk1 deficiency enhances the impairment of neurogenesis in Erk2-deficient mice.,The Journal of neuroscience : the official journal of the Society for Neuroscience,2018-01-19T20:11:00,31,3,1149-55,Satoh Y et al,doi: 10.1523/JNEUROSCI.2243-10.2011,,0001-01-19,,17496918,The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition.,Oncogene,2018-05-14T20:07:00,26,22,3227-39,Meloche S et al,,,0001-05-14,,23482492,MAPK1 is required for establishing the pattern of cell proliferation and for cell survival during lens development.,"Development (Cambridge, England)",2018-04-01T20:13:00,140,7,1573-82,Upadhya D et al,doi: 10.1242/dev.081042,,0001-04-01,,25320010,ERK mutations confer resistance to mitogen-activated protein kinase pathway inhibitors.,Cancer research,2017-12-01T20:14:00,74,23,7079-89,Goetz EM et al,doi: 10.1158/0008-5472.CAN-14-2073,,0001-12-01,,9604935,Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation.,Cell,0001-05-15,93,4,605-15,Khokhlatchev AV et al,,,0001-05-15,,9166761,The activating dual phosphorylation of MAPK by MEK is nonprocessive.,Biochemistry,0001-05-20,36,20,5929-33,Burack WR et al,,,0001-05-20,,22569528,"ERK1/2 MAP kinases: structure, function, and regulation.",Pharmacological research,2018-08-01T20:12:00,66,2,105-43,Roskoski R Jr,doi: 10.1016/j.phrs.2012.04.005,,0001-08-01,,25435214,Targeting RAS-ERK signalling in cancer: promises and challenges.,Nature reviews. Drug discovery,2017-12-01T20:14:00,13,12,928-42,Samatar AA et al,doi: 10.1038/nrd4281,,0001-12-01,
19723,GENE_SUMMARY,,"MAPK3 encodes a serine/threonine kinase involved in the MAPK signaling pathway. Amplifications of MAPK3 are found in breast and prostate cancers, among others.",,2017-04-10,,5595,MAPK3,mitogen-activated protein kinase 3,False,ENST00000263025,NM_002746.2,ERK-1,P44MAPK,PRKM3,ERK1,HUMKER1A,HS44KDAP,P44ERK1,ERT2,p44-MAPK,p44-ERK1,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
